Literature DB >> 28830208

Multiple Effects of Ginseng Berry Polysaccharides: Plasma Cholesterol Level Reduction and Enteric Neoplasm Prevention.

Jin-Yi Wan1,2, Wei-Hua Huang3,2, Wei Zheng2, Chan Woong Park4,5, Su Hwan Kim4, Dae Bang Seo4, Kwang-Soon Shin6, Jinxiang Zeng2, Haiqiang Yao2, Clara Sava-Segal2, Chong-Zhi Wang2, Chun-Su Yuan2.   

Abstract

The root of Asian ginseng (Panax ginseng C.A. Meyer) has been used for centuries in Oriental medicine to improve general well-being and to relieve various medical conditions. It is commonly understood that ginsenosides are responsible for the pharmacological activities of ginseng. Compared to the root of ginseng, studies on the berry are considerably limited. In this study, we evaluated the effects of polysaccharides from Asian ginseng berries on plasma lipid levels, chemically-induced enteric inflammation and neoplasm, and cancer chemoprevention in different experimental models. We tested two polysaccharide preparations: regular ginseng berry polysaccharide extract (GBPE) and ginseng berry polysaccharide portion (GBPP, removed MV [Formula: see text]). We first observed that both oral GBPE and oral GBPP significantly reduced plasma cholesterol and triglycerides levels in a dose-related manner in ob/ob mice, without obvious body weight changes. Then, in AOM/DSS-induced acute colitis mice, GBPE and GBPP significantly ameliorated the increased gut disease activity index and inhibited the reduction of the colon length. Further, the berry polysaccharides significantly suppressed chemically-induced pro-inflammatory cytokine levels. This is consistent with the observation that GBPE and GBPP attenuated tumorigenesis in mice by significantly and dose-dependently reducing tumor load. Finally, in vitro HCT-116 and HT-29 human colon cancer cells were used. While these berry preparations had better antiproliferation effects on the HCT-116 than the HT-29 cells, the GBPE had significantly stronger inhibitory effects than GBPP. The observed in vitro GBPE's effect could contribute to the actions of its small-molecule non-polysaccharide compounds due to their direct antiproliferative activities. Results obtained from the present study suggest that ginseng berry polysaccharides may have a therapeutic role in the management of high lipid levels, enteric inflammation, and colon malignancies.

Entities:  

Keywords:  Asia Ginseng; Azoxymethane; Chemoprevention; Cholesterol; Colorectal Cancer; Dextran Sodium Sulfate; Ginseng Berry; Inflammatory Cytokines; Panax ginseng; Polysaccharides; Triglyceride

Mesh:

Substances:

Year:  2017        PMID: 28830208     DOI: 10.1142/S0192415X17500719

Source DB:  PubMed          Journal:  Am J Chin Med        ISSN: 0192-415X            Impact factor:   4.667


  4 in total

1.  Effects of compound K, an enteric microbiome metabolite of ginseng, in the treatment of inflammation associated colon cancer.

Authors:  Haiqiang Yao; Jin-Yi Wan; Jinxiang Zeng; Wei-Hua Huang; Clara Sava-Segal; Lingru Li; Xin Niu; Qi Wang; Chong-Zhi Wang; Chun-Su Yuan
Journal:  Oncol Lett       Date:  2018-04-02       Impact factor: 2.967

2.  Anti-Cancer Effects of Panax ginseng Berry Polysaccharides via Activation of Immune-Related Cells.

Authors:  Dae-Young Lee; Chan Woong Park; Sue Jung Lee; Hye-Ryung Park; Su Hwan Kim; Seung-U Son; Jiyong Park; Kwang-Soon Shin
Journal:  Front Pharmacol       Date:  2019-11-26       Impact factor: 5.810

3.  Ginseng berry concentrate prevents colon cancer via cell cycle, apoptosis regulation, and inflammation-linked Th17 cell differentiation.

Authors:  C-Z Wang; C Wan; Y Luo; C-F Zhang; Q-H Zhang; L Chen; C W Park; S H Kim; Z Liu; M Lager; M Xu; L Hou; C-S Yuan
Journal:  J Physiol Pharmacol       Date:  2021-08-06       Impact factor: 3.011

4.  Ginseng berry polysaccharides on inflammation-associated colon cancer: inhibiting T-cell differentiation, promoting apoptosis, and enhancing the effects of 5-fluorouracil.

Authors:  Chong-Zhi Wang; Lifei Hou; Jin-Yi Wan; Haiqiang Yao; Jinbin Yuan; Jinxiang Zeng; Chan Woong Park; Su Hwan Kim; Dae Bang Seo; Kwang-Soon Shin; Chun-Feng Zhang; Lina Chen; Qi-Hui Zhang; Zhi Liu; Clara Sava-Segal; Chun-Su Yuan
Journal:  J Ginseng Res       Date:  2019-01-02       Impact factor: 6.060

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.